The DEPArray™ Kits streamline and optimize the analysis of FFPE samples by providing DEPArray™ users a fast and easy workflow, for a precise genetic analysis on pure cancer and stromal cell ...
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 27, 2021 /CNW/ -- Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of the new highly ...
Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB's DEPArray technology* to successfully recover low numbers of ...
Agreement comes almost a year after parent company expanded into U.S. clinical and diagnostics markets. Silicon Biosystems took a key step in developing its U.S. business by signing up Fox Chase ...
LOUISVILLE, Ky.--(BUSINESS WIRE)--PGXL Technologies and Silicon Biosystems, Inc. announced a collaborative partnership to make the highly regarded Silicon Biosystems DEPArray technology available ...
Menarini Silicon Biosystems Spa, Castel Maggiore, Italy. An increasing body of evidence demonstrates that intra-tumor heterogeneity (ITH), resulting from subclonal branch alterations arising during ...
SAN DIEGO--(BUSINESS WIRE)--Silicon Biosystems, Inc., a provider of specialized molecular and cellular biology technology, announced today that Baylor College of Medicine has agreed to purchase the ...
DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results